Nordic Nanovector Appoints Dr Christine Wilkinson Blanc as Chief Medical Officer
Oslo, Norway, 10 August 2020 Nordic Nanovector ASA (OSE: NANO) announces that Dr Christine Wilkinson Blanc has been appointed Chief Medical Officer with immediate effect. Dr Wilkinson Blanc is a seasoned pharmaceutical physician with broad experience in oncology and haematology with both large pharmaceutical and emerging biotechnology companies. She has over 25 years of experience in the pharmaceutical industry and has led multiple clinical studies across all phases for a wide range of indications. Dr Wilkinson Blanc joins us through her relationship with Weatherden, a specialist